Shares of Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) were down 3.1% during trading on Monday. The stock traded as low as $90.7250 and last traded at $90.7250. 30 shares changed hands during trading, a decline of 98% from the average session volume of 1,399 shares. The stock had previously closed at $93.61.
Cochlear Price Performance
The firm’s 50 day simple moving average is $93.07 and its two-hundred day simple moving average is $89.71.
Cochlear Company Profile
Cochlear Limited is an Australia-based medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may receive limited benefit from conventional hearing aids.
The company’s portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products. Cochlear also provides clinical support, rehabilitation resources, software and ongoing services for recipients, hearing professionals and healthcare providers.
Cochlear traces its origins to research led by Australian ear scientist Graeme Clark, whose work contributed to the development of the modern multichannel cochlear implant.
Recommended Stories
- Five stocks we like better than Cochlear
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
